CA2243706A1 - Azolyl piperazinyl phenyl oxazolidinone antimicrobials - Google Patents

Azolyl piperazinyl phenyl oxazolidinone antimicrobials

Info

Publication number
CA2243706A1
CA2243706A1 CA002243706A CA2243706A CA2243706A1 CA 2243706 A1 CA2243706 A1 CA 2243706A1 CA 002243706 A CA002243706 A CA 002243706A CA 2243706 A CA2243706 A CA 2243706A CA 2243706 A1 CA2243706 A1 CA 2243706A1
Authority
CA
Canada
Prior art keywords
carbon
azolyl
nitrogen
piperazinyl phenyl
phenyl oxazolidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002243706A
Other languages
French (fr)
Other versions
CA2243706C (en
Inventor
Robert C. Gadwood
Michael R. Barbachyn
Dana S. Toops
Herman W. Smith
Valerie A. Vaillancourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1997/001970 external-priority patent/WO1997030981A1/en
Publication of CA2243706A1 publication Critical patent/CA2243706A1/en
Application granted granted Critical
Publication of CA2243706C publication Critical patent/CA2243706C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compounds useful in the preparation of pharmaceutical preparations for the treatment of microbial infection where such compounds are of structural formula (I) or pharmaceutically acceptable salts thereof wherein: R1 is -CHO, -COCH3, -COCHCl2, -COCHF2, -CO2CH3, -SO2CH3, or -COCH2OH; X1 and X2 are independently H, F, or Cl; and Q is a five-membered ring heterocycle (azolyl ring) of general form (a) wherein A, B, and C, are independently oxygen (O), nitrogen (N), sulfur (S) or carbon (C). In all cases, the piperazine nitrogen atom is attached at the carbon atom of the carbon-nitrogen double bond.
CA002243706A 1996-02-26 1997-02-18 Azolyl piperazinyl phenyl oxazolidinone antimicrobials Expired - Fee Related CA2243706C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1231696P 1996-02-26 1996-02-26
US60/012,316 1996-02-26
PCT/US1997/001970 WO1997030981A1 (en) 1996-02-26 1997-02-18 Azolyl piperazinyl phenyl oxazolidinone antimicrobials

Publications (2)

Publication Number Publication Date
CA2243706A1 true CA2243706A1 (en) 1997-08-28
CA2243706C CA2243706C (en) 2005-10-04

Family

ID=35395933

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002243706A Expired - Fee Related CA2243706C (en) 1996-02-26 1997-02-18 Azolyl piperazinyl phenyl oxazolidinone antimicrobials

Country Status (1)

Country Link
CA (1) CA2243706C (en)

Also Published As

Publication number Publication date
CA2243706C (en) 2005-10-04

Similar Documents

Publication Publication Date Title
MY116093A (en) Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO2001007433A3 (en) Quinoline derivatives and their use as antibacterial agents
EP1182195A4 (en) Cyclic compounds and uses thereof
AU1625192A (en) Heterocyclic derivatives
AU6017296A (en) Isocoumarin derivatives and use thereof in drugs
NO996108L (en) 9 oksinerytromycinderivater
GB9305295D0 (en) Therapeutic compounds
NO20002434L (en) Oxazolidinone derivatives and pharmaceutical preparations
CA2203237A1 (en) Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
AU8156394A (en) Methods for inhibiting LDL oxidation and atheroclerosis
CA2146763A1 (en) Quinolone and acridinone derivatives for the treatment of urinary incontinence
HK1014138A1 (en) Benzenesulphonamide derivatives for the treatment of bladder instability
EP1078927A4 (en) Carbapenem derivatives, utilization thereof and intermediate compounds of the same
CA2243706A1 (en) Azolyl piperazinyl phenyl oxazolidinone antimicrobials
AU568996B2 (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
NO934741L (en) Procedure for minimizing and controlling ischemic and reperfusion injury
IE800900L (en) Pyrrolidinyl-benzoic acid derivatives.
CA2216787A1 (en) 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed